Brief Generation Agent
Converted brand plans, clinical evidence, segmentation data, and market insights into structured marketing briefs.
The Customer
A leading global pharmaceutical company was preparing to launch a new prescription brand into a highly competitive therapeutic category. The brand team needed creative campaign development that could withstand commercial, scientific, and regulatory scrutiny without slowing an aggressive launch timeline.
The traditional agency model worked against that goal. Sequential handoffs between strategy, creative, production, and review teams limited the number of ideas the team could explore, delayed decisions, and kept the client outside the creative process until formal presentations were ready.
The Challenge
The Solution
To overcome these constraints, Indegene partnered with the client to deploy its AI-native Agency of Record (Agentic AOR) model. The model transformed campaign development into a collaborative, real-time co-creation experience powered by specialized AI agents and senior creative experts.
AI-Powered Collaborative Campaign Development
Indegene designed a human-AI co-creation framework that turned the entire creative development journey, from strategy to concept validation, into an interactive, workshop-driven experience.
Built on Cortex, Indegene’s enterprise agentic orchestration platform, the solution brought together specialized AI agents, senior pharmaceutical strategists, creative leaders, and the client’s brand team in a single workflow. Instead of waiting weeks for agency presentations, the client generated, evaluated, and refined campaign ideas in real time.
A Specialized Agent Pipeline
A pipeline of specialized AI agents accelerated every stage of campaign development.
Challenge Statement Engine
Evaluated strategic options from a proprietary library of pharma-specific challenge archetypes, such as mindset shift and category reframing, and recommended the strongest campaign direction using explainable AI, providing clear rationale for every recommendation.
Creative Brief Agent
Translated strategy into a complete creative brief with motivation-belief-tension frameworks, promise statements, reasons to believe, and brand archetypes.
Concept AI
Generated campaign territories and visual concepts using pharmaceutical-specific creative patterns, enabling teams to explore multiple strategic directions simultaneously.
Governance by Design
Indegene embedded evaluation and compliance throughout the workflow rather than treating them as downstream activities. AI continuously scored briefs, campaign territories, and concepts against strategic objectives, while an MLR pre-flight layer identified potential regulatory risks and recommended improvements before formal review.
Human-AI Collaboration
Senior strategists and creative leaders remained involved throughout the process, applying judgment, scientific rigor, and commercial expertise while AI accelerated ideation, evaluation, and iteration.
A Compressed, Collaborative Workshop Series
Indegene replaced months of sequential agency handoffs with a 5-session co-creation workshop series that covered the entire creative lifecycle, from strategic alignment to concept validation. The client actively shaped campaign direction throughout the engagement instead of reviewing finished work at the end.
Outcomes
The Agentic AOR engagement changed both the speed and the experience of pharmaceutical campaign development for the client.
~97%
Reduction in creative development timeline (3 days vs. 3 months)
10x
Increase in concept volume explored (~100 vs. 10–15)
~50%
Reduction in concept development cost
Across a 3-day co-creation workshop series, the Agentic AOR model generated more than 100 concepts across 3 campaign platform directions, output that would typically take a traditional agency 3 months or more to produce. The team advanced 11 high-potential concepts to further evaluation and select directions moved into human-led design refinement.
The shift went beyond speed and volume. Visible decision logic let the client team see not just what the system recommended, but why, turning AI from a black box into a collaborative partner. And because the client shaped direction in the room in real time, the brand team moved from passive reviewer to active co-creator for the first time in the relationship.
The engagement proved that AI could do far more than accelerate existing creative workflows. By orchestrating specialized AI agents alongside experienced pharmaceutical experts, Indegene built a new operating model for creative development, one that combines greater speed, broader creative exploration, embedded governance, and active client participation.
The result is more than faster campaign development. It’s a scalable, continuously learning creative operating model that moves pharmaceutical organizations from agency delivery to true AI-enabled co-creation.